Literature DB >> 3608155

Total testosterone, free-androgen index, calculated free testosterone, and free testosterone by analog RIA compared in hirsute women and in otherwise-normal women with altered binding of sex-hormone-binding globulin.

T J Wilke, D J Utley.   

Abstract

We compared the clinical value of information on free testosterone as measured with the Coat-A-Count (Diagnostic Products Corp.) radioimmunoassay kit involving a ligand analog with that of total testosterone, the free-androgen index, and free testosterone calculated from concentrations of testosterone, sex-hormone-binding globulin, and albumin, in hirsute women, pregnant women, oral-contraceptive users, women with thyroid disease, and epileptic women taking phenytoin. Total testosterone, the free-androgen index, calculated free testosterone, and free testosterone by RIA were increased in 41-68% of hirsute women. Values for free testosterone increased in the first and third trimesters of pregnancy but remained within normal limits in all non-hirsute groups. Total testosterone was increased in patients having increased sex-hormone-binding globulin, whereas the free-androgen index and, to a lesser extent, calculated free testosterone were significantly decreased. Free testosterone measured by analog RIA not only has greater diagnostic efficiency than total testosterone, it also is technically simpler to determine than the free-androgen index and calculated free testosterone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3608155

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  18 in total

Review 1.  Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer.

Authors:  Laurence Klotz; Rodney H Breau; Loretta L Collins; Martin E Gleave; Tom Pickles; Frederic Pouliot; Fred Saad
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

2.  Comparison between buserelin and dexamethasone testing in the assessment of hirsutism.

Authors:  T Re; L Barbetta; C Dall'Asta; G Faglia; B Ambrosi
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

3.  Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement.

Authors:  Laurence Klotz; Bobby Shayegan; Chantal Guillemette; Loretta L Collins; Geoffrey Gotto; Dominique Guérette; Marie-Paule Jammal; Tom Pickles; Patrick O Richard; Fred Saad
Journal:  Can Urol Assoc J       Date:  2017-12-19       Impact factor: 1.862

Review 4.  Maximal testosterone suppression in prostate cancer--free vs total testosterone.

Authors:  Kyle O Rove; E David Crawford; Massimo Perachino; Juan Morote; Laurence Klotz; Paul H Lange; Gerald L Andriole; Alvin M Matsumoto; Samir S Taneja; Mario A Eisenberger; Leonardo O Reis
Journal:  Urology       Date:  2014-04-06       Impact factor: 2.649

Review 5.  Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians.

Authors:  Bobby Shayegan; Frédéric Pouliot; Alan So; John Fernandes; Joseph Macri
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

6.  Value of buserelin testing in the evaluation of hirsute women.

Authors:  B Ambrosi; T Re; E Passini; D Bochicchio; R Ferrario
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

Review 7.  Risk of Inflammatory Bowel Disease with Oral Contraceptives and Menopausal Hormone Therapy: Current Evidence and Future Directions.

Authors:  Hamed Khalili
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

8.  Defining a new testosterone threshold for medical castration: Results from a prospective cohort series.

Authors:  Shawn Dason; Christopher B Allard; Justin Tong; Bobby Shayegan
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

9.  LHRH Agonists for the Treatment of Prostate Cancer: 2012.

Authors:  Herbert Lepor; Neal D Shore
Journal:  Rev Urol       Date:  2012

10.  A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis.

Authors:  Elizabeth W Karlson; Lori B Chibnik; Monica McGrath; Shun-Chiao Chang; Brendan T Keenan; Karen H Costenbader; Patricia A Fraser; Shelley Tworoger; Susan E Hankinson; I-Min Lee; Julie Buring; Immaculata De Vivo
Journal:  Arthritis Res Ther       Date:  2009-06-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.